Titre : Empreinte génomique

Empreinte génomique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Meta-Analysis as Topic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Empreinte génomique : Questions médicales les plus fréquentes", "headline": "Empreinte génomique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Empreinte génomique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-14", "dateModified": "2025-04-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Empreinte génomique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Épigenèse génétique", "url": "https://questionsmedicales.fr/mesh/D044127", "about": { "@type": "MedicalCondition", "name": "Épigenèse génétique", "code": { "@type": "MedicalCode", "code": "D044127", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.308.203" } } }, "about": { "@type": "MedicalCondition", "name": "Empreinte génomique", "alternateName": "Genomic Imprinting", "code": { "@type": "MedicalCode", "code": "D018392", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Anne C Ferguson-Smith", "url": "https://questionsmedicales.fr/author/Anne%20C%20Ferguson-Smith", "affiliation": { "@type": "Organization", "name": "Department of Genetics, University of Cambridge, Downing Street, Cambridge CB2 3EH, UK." } }, { "@type": "Person", "name": "Thomas Eggermann", "url": "https://questionsmedicales.fr/author/Thomas%20Eggermann", "affiliation": { "@type": "Organization", "name": "Institute for Human Genetics and Genomic Medicine, Medical Faculty, RWTH University Aachen, Pauwelsstr. 3, D-52074 Aachen, Germany." } }, { "@type": "Person", "name": "Simon Hippenmeyer", "url": "https://questionsmedicales.fr/author/Simon%20Hippenmeyer", "affiliation": { "@type": "Organization", "name": "Institute of Science and Technology Austria, Am Campus 1, 3400 Klosterneuburg, Austria. Electronic address: simon.hippenmeyer@ist.ac.at." } }, { "@type": "Person", "name": "Jinsoo Ahn", "url": "https://questionsmedicales.fr/author/Jinsoo%20Ahn", "affiliation": { "@type": "Organization", "name": "Functional Genomics Laboratory, Department of Animal Sciences, The Ohio State University, Columbus, OH 43210, USA." } }, { "@type": "Person", "name": "In-Sul Hwang", "url": "https://questionsmedicales.fr/author/In-Sul%20Hwang", "affiliation": { "@type": "Organization", "name": "Animal Biotechnology Division, National Institute of Animal Science, Rural Development Administration, Wanju 55365, Korea." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Medical Management of Headache and Facial Pain in CRS: A Systematic Review and Meta-Analysis.", "datePublished": "2024-05-10", "url": "https://questionsmedicales.fr/article/38727514", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/lary.31502" } }, { "@type": "ScholarlyArticle", "name": "The effect of social anxiety on threat acquisition and extinction: a systematic review and meta-analysis.", "datePublished": "2024-05-09", "url": "https://questionsmedicales.fr/article/38737738", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7717/peerj.17262" } }, { "@type": "ScholarlyArticle", "name": "The Effects of Osteopathic Manipulative Treatment (OMT) on Postoperative Length of Stay: A Meta-Analysis.", "datePublished": "2024-05-09", "url": "https://questionsmedicales.fr/article/38854331", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7759/cureus.59983" } }, { "@type": "ScholarlyArticle", "name": "Evaluation of the impact of prospective payment systems on cholecystectomy: A systematic review and meta-analysis.", "datePublished": "2024-05-07", "url": "https://questionsmedicales.fr/article/38710538", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.14701/ahbps.24-038" } }, { "@type": "ScholarlyArticle", "name": "Incidence and Association of Uveitis with COVID-19 Vaccination: A Systematic Review and Meta-Analysis.", "datePublished": "2024-05-06", "url": "https://questionsmedicales.fr/article/38709174", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/09286586.2024.2343714" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes génétiques", "item": "https://questionsmedicales.fr/mesh/D055614" }, { "@type": "ListItem", "position": 3, "name": "Régulation de l'expression des gènes", "item": "https://questionsmedicales.fr/mesh/D005786" }, { "@type": "ListItem", "position": 4, "name": "Épigenèse génétique", "item": "https://questionsmedicales.fr/mesh/D044127" }, { "@type": "ListItem", "position": 5, "name": "Empreinte génomique", "item": "https://questionsmedicales.fr/mesh/D018392" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Empreinte génomique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Empreinte génomique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Empreinte génomique", "description": "Comment diagnostiquer une empreinte génomique ?\nQuels tests sont utilisés pour l'empreinte génomique ?\nPeut-on détecter l'empreinte génomique in utero ?\nQuels signes cliniques indiquent une empreinte génomique ?\nL'empreinte génomique est-elle héréditaire ?", "url": "https://questionsmedicales.fr/mesh/D018392?mesh_terms=Meta-Analysis+as+Topic&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Empreinte génomique", "description": "Quels sont les symptômes d'une empreinte génomique ?\nL'empreinte génomique cause-t-elle des maladies ?\nY a-t-il des symptômes spécifiques aux enfants ?\nLes symptômes varient-ils selon le parent affecté ?\nComment l'empreinte génomique affecte-t-elle le développement ?", "url": "https://questionsmedicales.fr/mesh/D018392?mesh_terms=Meta-Analysis+as+Topic&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Empreinte génomique", "description": "Peut-on prévenir les troubles liés à l'empreinte génomique ?\nLe dépistage prénatal aide-t-il à prévenir ces troubles ?\nLes habitudes de vie influencent-elles l'empreinte génomique ?\nLe suivi médical régulier est-il important ?\nLes facteurs environnementaux jouent-ils un rôle ?", "url": "https://questionsmedicales.fr/mesh/D018392?mesh_terms=Meta-Analysis+as+Topic&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Empreinte génomique", "description": "Quels traitements existent pour les troubles liés à l'empreinte génomique ?\nPeut-on guérir les maladies liées à l'empreinte génomique ?\nLes thérapies géniques sont-elles une option ?\nComment gérer les symptômes au quotidien ?\nY a-t-il des médicaments spécifiques pour ces troubles ?", "url": "https://questionsmedicales.fr/mesh/D018392?mesh_terms=Meta-Analysis+as+Topic&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Empreinte génomique", "description": "Quelles complications peuvent survenir ?\nL'empreinte génomique augmente-t-elle le risque de cancer ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la vie quotidienne ?\nY a-t-il des complications à long terme ?", "url": "https://questionsmedicales.fr/mesh/D018392?mesh_terms=Meta-Analysis+as+Topic&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Empreinte génomique", "description": "Quels sont les facteurs de risque d'empreinte génomique ?\nL'âge parental influence-t-il le risque ?\nLes facteurs environnementaux sont-ils significatifs ?\nLes maladies génétiques augmentent-elles le risque ?\nLe mode de vie influence-t-il l'empreinte génomique ?", "url": "https://questionsmedicales.fr/mesh/D018392?mesh_terms=Meta-Analysis+as+Topic&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une empreinte génomique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests génétiques et l'analyse des marqueurs épigénétiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour l'empreinte génomique ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme l'analyse de méthylation de l'ADN sont couramment utilisés." } }, { "@type": "Question", "name": "Peut-on détecter l'empreinte génomique in utero ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests prénataux peuvent identifier des anomalies liées à l'empreinte génomique." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une empreinte génomique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies de croissance ou des troubles métaboliques peuvent indiquer ce phénomène." } }, { "@type": "Question", "name": "L'empreinte génomique est-elle héréditaire ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être transmise de manière parentale, affectant la descendance." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une empreinte génomique ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes varient, incluant des retards de développement et des troubles métaboliques." } }, { "@type": "Question", "name": "L'empreinte génomique cause-t-elle des maladies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est liée à des maladies comme le syndrome de Prader-Willi et d'Angelman." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques aux enfants ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants peuvent présenter des troubles de l'alimentation et des problèmes de comportement." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le parent affecté ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent différer selon que l'anomalie provient de la mère ou du père." } }, { "@type": "Question", "name": "Comment l'empreinte génomique affecte-t-elle le développement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut influencer la croissance, le métabolisme et le comportement des individus." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles liés à l'empreinte génomique ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est difficile, mais le conseil génétique peut aider les familles à risque." } }, { "@type": "Question", "name": "Le dépistage prénatal aide-t-il à prévenir ces troubles ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage prénatal peut identifier des risques d'empreinte génomique." } }, { "@type": "Question", "name": "Les habitudes de vie influencent-elles l'empreinte génomique ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Certaines habitudes peuvent influencer l'expression des gènes, mais la recherche est en cours." } }, { "@type": "Question", "name": "Le suivi médical régulier est-il important ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi médical peut aider à détecter précocement des anomalies liées à l'empreinte." } }, { "@type": "Question", "name": "Les facteurs environnementaux jouent-ils un rôle ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs environnementaux peuvent influencer l'expression des gènes et l'empreinte." } }, { "@type": "Question", "name": "Quels traitements existent pour les troubles liés à l'empreinte génomique ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements sont symptomatiques, incluant thérapies comportementales et soutien nutritionnel." } }, { "@type": "Question", "name": "Peut-on guérir les maladies liées à l'empreinte génomique ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de cure, mais des traitements peuvent améliorer la qualité de vie." } }, { "@type": "Question", "name": "Les thérapies géniques sont-elles une option ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en recherche, mais pas encore une option standard pour ces troubles." } }, { "@type": "Question", "name": "Comment gérer les symptômes au quotidien ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une approche multidisciplinaire incluant médecins, nutritionnistes et psychologues est recommandée." } }, { "@type": "Question", "name": "Y a-t-il des médicaments spécifiques pour ces troubles ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de médicaments spécifiques, mais des traitements peuvent aider à gérer les symptômes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles métaboliques, des retards de développement et des problèmes comportementaux." } }, { "@type": "Question", "name": "L'empreinte génomique augmente-t-elle le risque de cancer ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent un lien entre l'empreinte génomique et un risque accru de cancer." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais beaucoup ne sont pas réversibles." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la vie quotidienne ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent limiter les activités, nécessitant un soutien constant et des adaptations." } }, { "@type": "Question", "name": "Y a-t-il des complications à long terme ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications à long terme peuvent inclure des problèmes de santé chroniques." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque d'empreinte génomique ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux et des anomalies chromosomiques." } }, { "@type": "Question", "name": "L'âge parental influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'âge avancé des parents peut augmenter le risque d'anomalies liées à l'empreinte." } }, { "@type": "Question", "name": "Les facteurs environnementaux sont-ils significatifs ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains facteurs environnementaux peuvent influencer l'expression des gènes." } }, { "@type": "Question", "name": "Les maladies génétiques augmentent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies génétiques dans la famille peuvent augmenter le risque d'empreinte génomique." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il l'empreinte génomique ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines habitudes de vie, comme l'alimentation, peuvent influencer l'expression génétique." } } ] } ] }

Sources (10000 au total)

Medical Management of Headache and Facial Pain in CRS: A Systematic Review and Meta-Analysis.

This study aims to characterize the effect of medical therapy on headache and facial pain/pressure among patients with chronic rhinosinusitis (CRS).... CINAHL, PubMed, and Scopus.... CINAHL, PubMed, and Scopus were searched from inception through April 10th, 2024, for English language articles reporting headache or facial pain/pressure outcomes in CRS patients. Inclusion was restr... The initial search yielded 2429 unique articles. After a full-text review of 272 articles, 17 studies reporting outcomes for 2269 patients were included in the meta-analysis. The mean patient age was ... Our findings suggest medical therapy significantly reduces facial pain and pressure in the CRS population. Laryngoscope, 2024....

Incidence and Association of Uveitis with COVID-19 Vaccination: A Systematic Review and Meta-Analysis.

In the wake of the COVID-19 pandemic, vaccines have been pivotal in curbing disease spread and severity. However, concerns over post-vaccination adverse events, including uveitis, an inflammatory ocul... A literature search was performed across several databases on October 21, 2023. Human studies examining the incidence of uveitis post-COVID-19 vaccination were included. The Newcastle-Ottawa Scale was... Six studies involving over 2 billion vaccine doses were included. The overall incidence of uveitis was 0.016% (95% CI: 0.010 to 0.026). No significant association was found between vaccination and the... This analysis indicates a low incidence of uveitis following COVID-19 vaccination and no significant association with the vaccine. The findings are constrained by the small number of studies and low c...

Relaxation Therapy and Human Milk Feeding Outcomes: A Systematic Review and Meta-Analysis.

Human milk feeding is a key public health goal to optimize infant and maternal/parental health, but global lactation outcomes do not meet recommended duration and exclusivity. There are connections be... To appraise all available evidence on whether the provision of relaxation interventions to lactating individuals improves lactation and well-being.... Embase, MEDLINE, CINAHL, Allied and Complementary Medicine Database, Web of Science, and the Cochrane Library were searched on September 30, 2023, and topic experts were consulted.... Two independent reviewers screened for eligibility. Inclusion criteria were full-text, peer-reviewed publications with a randomized clinical trial design. Techniques that were entirely physical (eg, m... Two independent reviewers extracted data and assessed risk of bias with the Cochrane Risk of Bias 2 tool. Fixed-effects meta-analysis and Grading of Recommendations, Assessment, Development, and Evalu... Prespecified primary outcomes were human milk quantity, length and exclusivity of human milk feeding, milk macronutrients/cortisol, and infant growth and behavior.... A total of 16 studies were included with 1871 participants (pooled mean [SD] age for 1656 participants, 29.6 [6.1] years). Interventions were music, guided relaxation, mindfulness, and breathing exerc... Results of this systematic review and meta-analysis suggest that provision of relaxation was associated with an increase in human milk quantity and infant weight gain and a slight reduction in stress ...

The burden of health expenditure on household impoverishment in Ethiopia: a systematic review and meta-analysis.

Ethiopia, like many low-income countries, faces significant challenges in providing accessible and affordable healthcare to its population. Health expenditure is a critical factor in determining the q... This systematic review and meta-analysis used the updated Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. PubMed, Cochrane Library, HINARI, Google Scholar and Ep... This systematic review and meta-analysis included a total of 12 studies with a sample size of 66344 participants. The pooled incidence of impoverishment, among households, attributed to health expendi... The pooled incidence of impoverishment of households attributed to their health expenditure in Ethiopia was higher than the incidence of impoverishment reported by the world health organization in 202...

Prevalence and clinical implications of sarcopenia in breast cancer: a systematic review and meta-analysis.

The impact of sarcopenia in oncology is increasingly recognized, yet little is known about its clinical implications in breast cancer. This systematic review and meta-analysis estimates the overall pr... We systematically searched primary original research published before June 2023 in four databases: the Cochrane Library via Wiley, CINAHL Plus with Full Text, Embase via Elsevier Excerpta Medica, and ... The systematic review included 17 studies with a total of 9863 patients; the meta-analysis included 12 of these studies. The mean prevalence of sarcopenia in breast cancer (stages I-III) was 32.5%. Th... Sarcopenia is not just a state of muscle mass loss, but an influencing factor on therapeutic effects and survival rates in oncology. It is thus necessary to recognize the risk of sarcopenia throughout...

Risk of dementia and Alzheimer's disease associated with antidiabetics: A Bayesian network meta-analysis.

Dementia risk is substantially elevated in patients with diabetes. However, evidence on dementia risk associated with various antidiabetic regimens is still limited. This study aims to comprehensively... Cochrane Central Register of Controlled Trials, Embase, MEDLINE (PubMed) and Scopus were searched from inception to March 2024 (PROSPERO CRD 42022365927). Observational studies investigating dementia ... A total of 1,565,245 patients from 16 studies were included. Dementia and AD risks were significantly lower with metformin and sodium glucose co-transporter-2 inhibitors (SGLT2i). Metformin displayed ... Metformin and SGLT2i demonstrated lower dementia risk than other antidiabetic classes. Patient-specific factors may affect this relationship and cautious interpretation is warranted as metformin is ty...